EGFR and neoplasm: The antibody recognizes both wtEGFR and EGFRvIII. Patients with a high EGFR expression seemed to present worse clinic neurological status and radiological features of tumour aggressiveness. The antibody recognizes both wtEGFR and EGFRvIII.